S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arena PharmaceuticalsPTC TherapeuticsEidos TherapeuticsSage TherapeuticsMaravai LifeSciences
SymbolNASDAQ:ARNANASDAQ:PTCTNASDAQ:EIDXNASDAQ:SAGENASDAQ:MRVI
Price Information
Current Price$80.35$57.10$122.21$85.00$32.52
52 Week RangeBuyBuyHoldHoldBuy
MarketRank™
Overall Score1.31.31.01.21.9
Analysis Score2.53.31.02.22.5
Community Score2.42.52.33.15.0
Dividend Score0.00.00.00.00.0
Ownership Score1.70.01.70.00.0
Earnings & Valuation Score0.00.60.00.61.9
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$90.21$63.75$53.45$80.28$33.86
% Upside from Price Target12.28% upside11.65% upside-56.26% downside-5.56% downside4.11% upside
Trade Information
Market Cap$4.85 billion$3.90 billion$4.75 billion$4.42 billion$5.48 billion
Beta0.831.22-0.162.23N/A
Average Volume474,084543,211128,113502,1631,088,624
Sales & Book Value
Annual Revenue$806.43 million$306.98 million$26.69 million$6.87 millionN/A
Price / Sales6.0112.69177.99722.34N/A
Cashflow$7.88 per shareN/AN/AN/AN/A
Price / Cash10.20N/AN/AN/AN/A
Book Value$21.38 per share$9.64 per share$4.57 per share$18.23 per shareN/A
Price / Book3.765.9226.744.66N/A
Profitability
Net Income$397.55 million$-251,580,000.00$-37,830,000.00$-680,240,000.00N/A
EPS$7.69($3.45)($1.03)($13.38)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/A55.12
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-123.19%N/A-7,706.84%N/A
Return on Equity (ROE)-33.17%-76.10%-65.21%-63.81%N/A
Return on Assets (ROA)-30.41%-24.60%-53.04%-56.64%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.04%1.89%0.14%N/AN/A
Current Ratio23.17%4.90%11.10%11.71%N/A
Quick Ratio23.17%4.83%11.10%11.71%N/A
Ownership Information
Institutional Ownership Percentage89.67%N/A31.40%N/AN/A
Insider Ownership Percentage3.05%7.00%70.10%4.80%N/A
Miscellaneous
Employees32075470675N/A
Shares Outstanding60.34 million68.24 million38.87 million58.38 million168.66 million
Next Earnings Date5/6/2021 (Estimated)4/29/2021 (Estimated)N/A5/6/2021 (Estimated)3/2/2021 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.